Filter
1953
Filtered Results: 1953
Text search:
trials
guidelines
Featured
Recommendations
210
New Publications
376
Language
Document type
No document type
1060
Guidelines
375
Studies & Reports
301
Manuals
93
Strategic & Response Plan
44
Fact sheets
35
Training Material
23
Situation Updates
8
Infographics
6
Resource Platforms
5
Brochures
2
Videos
1
Countries / Regions
India
107
Global
81
South Africa
54
Kenya
41
Western and Central Europe
33
Africa
28
Nigeria
23
Ethiopia
23
Uganda
22
Sierra Leone
19
Zambia
19
Nepal
17
Tanzania
17
Malawi
17
Eastern Europe
16
Russia
16
Philippines
15
Brazil
15
Latin America and the Carribbean
15
Liberia
14
Ghana
14
Ukraine
14
Zimbabwe
13
Rwanda
13
Indonesia
13
East and Southern Africa
12
Bangladesh
11
West and Central Africa
11
South–East Asia Region
11
Asia
11
Namibia
10
Congo, Democratic Republic of
8
South Sudan
8
Mozambique
8
Lesotho
7
USA
6
Cameroon
6
Germany
6
Syria
6
Eswatini/ Swaziland
6
Colombia
6
Botswana
6
Guinea
5
Senegal
5
Cambodia
5
Thailand
5
Peru
5
Myanmar / Burma
5
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Burkina Faso
4
Haiti
4
Argentina
4
Albania
4
United Kingdom
4
Guinea-Bissau
3
Lebanon
3
Sudan
3
Angola
3
Georgia
3
Vietnam
3
North America
3
Spain
3
Morocco
2
Pakistan
2
Iraq
2
China
2
Burundi
2
Mexico
2
Sri Lanka
2
Western Pacific Region
2
Paraguay
2
Venezuela
2
Laos
2
Tajikistan
2
Estonia
2
Iran
2
Kyrgyzstan
2
Portugal
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Singapore
1
Benin
1
Central African Republic
1
North Macedonia
1
Hungary
1
Ecuador
1
Greece
1
Madagascar
1
Chile
1
Bulgaria
1
Kazakhstan
1
Jamaica
1
Denmark
1
France
1
Tunisia
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
500
Clinical Guidelines
322
Public Health
152
Women & Child Health
128
Key Resources
41
Pharmacy & Technologies
27
Capacity Building
23
Toolboxes
Mental Health
243
HIV
222
COVID-19
172
TB
167
NCDs
87
AMR
60
NTDs
59
Caregiver
53
Pharmacy
46
Rapid Response
45
Ebola
36
Planetary Health
32
Disability
25
Conflict
21
Refugee
17
Global Health Education
15
Polio
12
Zika
9
Cholera
7
Natural Hazards
6
Specific Hazards
5
Social Ethics
4
Health Financing Toolbox
4
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time a new class of Mycobacterium tuberculosis antigen-based skin tests (TBSTs), and the two existing classes of tests: the tuberculin skin test (TST) and t...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Buruli ulcer : management of Mycobacterium ulcerans disease : a manual for health care providers
recommended
This manual is addressed to health care providers dealing with Mycobacterium ulcerans disease (Buruli ulcer). The manual aims to achieve a better understanding of the disease, its clinical presentation and its surgical management. The manual is aimed particularly at district health care providers. A...
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledge
acquired and produced by the UN system on drug-r...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim...
Kangaroo mother care: a practical guide
recommended
Kangaroo mother care is a method of care of preterm infants. The method involves infants being carried, usually by the mother, with skin-to-skin contact. This guide is intended for health professionals responsible for the care of low-birth-weight and preterm infants. Designed to be adapted to local ...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Obesity and diet-related noncommunicable diseases (NCDs) have been steadily increasing globally, and with them, a pressing need to implement effective responses to address the contributing factors. Among the available evidence-based policy options that enable healthier choices and improved diets is ...
The COVID-19 pandemic has raised profound ethical challenges on an unprecedented global scale. These challenges include how to allocate scarce resources (especially vaccines and therapeutics), both within and between countries, whether and when to mandate vaccines and/or masks, whether and how to co...
The indicators and questions in this document are designed for use by national AIDS programmes and partners to assess the state of a country’s HIV and AIDS response, and to measure progress towards achieving national HIV targets. Countries are encouraged to integrate these indicators and questions...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
